Skip to Content

Zantac

In the US, Zantac (ranitidine systemic) is a member of the drug class H2 antagonists and is used to treat Duodenal Ulcer, Duodenal Ulcer Prophylaxis, Erosive Esophagitis, Gastric Ulcer Maintenance Treatment, Gastrointestinal Hemorrhage, GERD, Indigestion, Pathological Hypersecretory Conditions, Stomach Ulcer, Stress Ulcer Prophylaxis, Surgical Prophylaxis and Zollinger-Ellison Syndrome.

US matches:

UK matches:

Ingredient matches for Zantac

Ranitidine

Ranitidine is reported as an ingredient of Zantac in the following countries:

  • Egypt
  • Italy
  • Lebanon
  • Malta
  • Peru
  • Poland
  • Taiwan
  • Turkey
  • United States
  • Vietnam

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Zantac in the following countries:

  • Australia
  • Austria
  • Bangladesh
  • Belgium
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Denmark
  • Ecuador
  • Estonia
  • Finland
  • Georgia
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Lithuania
  • Malaysia
  • Malta
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Philippines
  • Portugal
  • Romania
  • Singapore
  • South Africa
  • Spain
  • Sweden
  • Thailand
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide